Keyphrases
Convection-enhanced Delivery
75%
Fusion Protein
66%
Glioblastoma Cell Lines
60%
Immunodeficient Mice
60%
Linker
58%
Diphtheria Toxin
51%
In Vitro Toxicity
50%
Molecular Modification
50%
Nude Rat
50%
T Cells
50%
Immunotoxin
50%
Human Glioblastoma
50%
Recombinant
50%
Ligand-directed
50%
Bispecific
50%
Glioblastoma multiforme
50%
Glioblastoma
50%
DT390
41%
Prolonged Survival
41%
Brain Tumor
35%
Tumor Growth
35%
Amino Acids
35%
Intracranial Administration
25%
Tumor Volume Reduction
25%
Highly Selective
25%
Highly Effective
25%
Maximum Tolerated Dose
25%
Gene Splicing
25%
Therapeutic Efficacy
25%
Effective Treatment
25%
Every Other Day
25%
Magnetic Resonance Imaging
25%
Tumor Volume
25%
Recombinant Fusion Proteins
25%
Nude Mice
25%
Amino-terminal Fragment
25%
Fold Increase
25%
Vascular Damage
25%
U87MG
25%
Tumor Model
25%
Xenograft
25%
Hybrid Fusion
25%
Splicing Technique
25%
In Vitro Study
25%
Urokinase-type Plasminogen Activator
25%
T-cell Malignancies
16%
Aggressive Therapy
16%
Constant Region
16%
Weight Loss
16%
SCID Mice
16%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Chimeric Protein
75%
Intracranial Tumor
62%
Neoplasm
55%
Molecular Modification
50%
Immunotoxin
50%
T Cell Leukemia
50%
Elimination
50%
Nude Rat
50%
CD3 Antigen
50%
Diphtheria Toxin
47%
T Lymphocyte Receptor
25%
IC50
25%
Disease
25%
Tumor Growth
22%
Amino Acid
22%
Nude Mouse
12%
Tumor Model
12%
Blood Vessel Injury
12%
Urokinase
12%
Combination Therapy
12%
Maximum Tolerated Dose
12%
Interleukin 13
10%
Firefly Luciferase
10%
Enzyme-Linked Immunosorbent Assay
10%
Growth Factor
10%
Luciferase
10%
Neuroscience
Intracranial Tumor
66%
Cell Line
58%
Chimeric Protein
50%
In Vitro
41%
Diphtheria
41%
Amino Acid
41%
Reporter Gene
25%
Firefly Luciferase
25%
Growth Factor
25%
ELISA
25%
Interleukin 13
25%
Luciferase
25%
Magnetic Resonance Imaging
16%
Urokinase
16%
RNA Splicing
16%
Splicing Technique
16%
Amino Terminal Sequence
16%
